drugset / Trial / NCT06780124
Сlinical Study Aiming to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Ascending Doses of ZE63-0302 in Healthy Volunteers
RandomizedSequentialDouble-blindTreatment
Summary
A first-in-human study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of single and multiple ascending doses of ZE63-0302 administered orally in healthy volunteers.
Timeline
- Start
- 2024-04-12
- Primary completion
- 2025-06-24
- Completion
- 2025-11-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ZE63-0302 | Unknown | 20 mg | Oral |
| Subject | ZE63-0302 | Unknown | 100 mg | Oral |
| Subject | ZE63-0302 | Unknown | 300 mg | Oral |
| Subject | ZE63-0302 | Unknown | 600 mg | Oral |
Indications
No indication recorded.